TomoTherapy adds Lance Balk to board of directors

Radiotherapy solutions provider TomoTherapy has appointed Lance C. Balk to its board of directors, effective  May 5.

According to the Madison, Wis.-based company, Balk has most recently served as senior vice president and general counsel for Siemens Healthcare Diagnostics and prior to this appointment, he was a member of the executive leadership team of both Siemens DX and its predecessor company, Dade Behring.

 

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.